Labcorp Holdings Inc. LH

309.64 0.69 0.22% as of 25 Sep
Market cap
$21.9B
P/E
25.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
11.74% 11.05% 10.51% 10.14%

+8 more TTM periods

ROA
5.48% 5.13% 4.77% 4.64%
ROIC
6.50% 6.59% 6.54% 6.29%
Return on Tangible Assets
20.92% 18.89% 20.49% 18.74%
Average Days of Receivables
63.72 63.24 59.14 60.06
Free Cash Flow per Share
14.33 17.00 14.59 16.68
Free Cash Flow
1,170.50 1,399.30 1,214.00 1,385.70
Capital Expenditures
(467.90) (414.20) (426.50) (417.80)
Piotroski F-Score
7.00 6.00 7.00 8.00
Other line items
Cash ROIC
11.17% 11.62% 11.47% 12.49%
Accounts Receivable Turnover
6.00 5.99 6.40 6.13
Accounts Payable Turnover
13.78 14.24 11.58 14.82
Inventory Turnover
19.07 20.42 19.34 19.61
Average Days of Payables
24.63 25.23 30.88 24.77
Days of Inventory on Hand
20.11 18.05 19.64 19.33
Tax Rate
(0.19) (0.18) (0.21) (0.22)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
15.47% 15.70% 15.89% 16.51%
Share Based Compensation of Revenue
0.87% 0.88% 0.90% 0.90%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.63 1.93 1.87 2.11
Depreciation/Fixed assets
0.22 0.22 0.22 0.22
Capex/Depreciation
(0.67) (0.60) (0.63) (0.62)
Revenue per Share
175.62 171.86 167.69 165.65
Operating CF per Share
20.05 22.04 19.72 21.70
Capex per Share
(5.73) (5.03) (5.13) (5.03)
Capex to Sales
0.03 0.03 0.03 0.03
Net Profit Margin
6.99% 6.66% 6.28% 6.21%

Fold the line items

Columns are period end dates